Cargando…
Advances and Obstacles in Homology-Mediated Gene Editing of Hematopoietic Stem Cells
Homology-directed gene editing of hematopoietic stem and progenitor cells (HSPCs) is a promising strategy for the treatment of inherited blood disorders, obviating many of the limitations associated with viral vector-mediated gene therapies. The use of CRISPR/Cas9 or other programmable nucleases and...
Autores principales: | Salisbury-Ruf, Christi T., Larochelle, Andre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867106/ https://www.ncbi.nlm.nih.gov/pubmed/33535527 http://dx.doi.org/10.3390/jcm10030513 |
Ejemplares similares
-
Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration
por: Bloomer, Hanan, et al.
Publicado: (2021) -
Homology-directed gene-editing approaches for hematopoietic stem and progenitor cell gene therapy
por: Azhagiri, Manoj Kumar K., et al.
Publicado: (2021) -
De Novo Generation of Human Hematopoietic Stem Cells from Pluripotent Stem Cells for Cellular Therapy
por: Ding, Jianyi, et al.
Publicado: (2023) -
Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing
por: Anurogo, Dito, et al.
Publicado: (2021) -
The p53 challenge of hematopoietic stem cell gene editing
por: Dorset, Sofie R., et al.
Publicado: (2023)